ASSETMARK, INC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.

Quarter-by-quarter ownership
ASSETMARK, INC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$1,106,642
-1.5%
71,535
+0.0%
0.00%0.0%
Q2 2023$1,123,799
+2.4%
71,534
+7.4%
0.00%
-20.0%
Q1 2023$1,097,370
+370.8%
66,588
+345.7%
0.01%
+400.0%
Q4 2022$233,064
+29.5%
14,940
+7.9%
0.00%0.0%
Q3 2022$180,000
-0.6%
13,850
+7.7%
0.00%0.0%
Q2 2022$181,000
-8.6%
12,862
-6.9%
0.00%0.0%
Q1 2022$198,000
+14.5%
13,822
+9.1%
0.00%0.0%
Q4 2021$173,000
-12.2%
12,670
+5.6%
0.00%0.0%
Q3 2021$197,000
-82.6%
12,003
-80.7%
0.00%
-83.3%
Q4 2020$1,129,000
+69.3%
62,049
+66.0%
0.01%
+50.0%
Q3 2020$667,000
+31.8%
37,369
+32.3%
0.00%0.0%
Q2 2020$506,000
+72.1%
28,235
+45.6%
0.00%
+100.0%
Q1 2020$294,000
-83.5%
19,392
-78.5%
0.00%
-85.7%
Q4 2019$1,783,000
+119.3%
90,378
+91.2%
0.01%
+100.0%
Q3 2019$813,000
+515.9%
47,274
+535.0%
0.01%
+600.0%
Q2 2019$132,000
+371.4%
7,445
+443.4%
0.00%
Q1 2019$28,0001,3700.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2020
NameSharesValueWeighting ↓
Adelphi Capital LLP 8,958,784$176,757,00033.75%
Ovata Capital Management Ltd 879,800$17,557,092,00013.04%
Paulson & Co. 13,244,711$261,318,0005.64%
Glenview Capital Management 30,582,721$603,397,0005.28%
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC 718,028$14,167,0004.85%
Velanne Asset Management Ltd 302,694$5,972,0003.52%
Blackcrane Capital, LLC 172,708$3,408,0002.72%
Melqart Asset Management (UK) Ltd 1,557,000$30,720,0002.57%
GMT CAPITAL CORP 3,345,976$66,016,0002.55%
REDWOOD CAPITAL MANAGEMENT, LLC 827,955$16,336,0002.24%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders